107 related articles for article (PubMed ID: 3431610)
1. Activity of lymphocytes and antibodies derived from aging and adult rats bearing a MC-induced tumor in the syngeneic ADCC test.
Nowak JJ; Ziółkowska M; Ryzewska A
Neoplasma; 1987; 34(6):703-11. PubMed ID: 3431610
[TBL] [Abstract][Full Text] [Related]
2. ADCC in aging rats with methylcholanthrene-induced sarcoma (MC-Sa).
Ziółkowska M; Nowak JJ; Ryzewska A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):853-62. PubMed ID: 3508042
[TBL] [Abstract][Full Text] [Related]
3. Methylcholanthrene-induced tumors in adult and in aging rats: infiltrating cells and their ADCC activity.
Nowak JJ; Ziółkowska M; Ryzewska A
Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):275-85. PubMed ID: 2102660
[TBL] [Abstract][Full Text] [Related]
4. FcR+ lymphocytes and ADCC in tumor-bearing adult and aging rats.
Nowak JJ; Ziółkowska M; Ryzewska A
Arch Immunol Ther Exp (Warsz); 1988; 36(1):45-53. PubMed ID: 3233063
[TBL] [Abstract][Full Text] [Related]
5. Recombinant tumor necrosis factor alpha inhibits growth of methylcholanthrene-induced sarcoma and enhances natural killer activity of tumor-infiltrating lymphocytes in aging rats.
Ziółkowska M; Nowak JJ; Janiak M; Ryzewska A
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):357-64. PubMed ID: 8010877
[TBL] [Abstract][Full Text] [Related]
6. Separation of cell-dependent antibody (CDA) and inhibitory antibody by protein-A affinity chromatography and the effect of fractions on antibody-dependent cellular cytotoxicity (ADCC).
Sato N; Yabuki Y; Toh K; Ishii Y; Kikuchi K
Immunology; 1979 Mar; 36(3):421-6. PubMed ID: 437836
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
Jurin M; Suit HD
Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
[No Abstract] [Full Text] [Related]
8. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
[TBL] [Abstract][Full Text] [Related]
9. Immunity to chemically induced rat sarcomas: study of the specificity of cytotoxic cells.
Goguel AF; Nauciel C
Ann Immunol (Paris); 1979; 130C(5):621-34. PubMed ID: 316679
[TBL] [Abstract][Full Text] [Related]
10. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
[TBL] [Abstract][Full Text] [Related]
11. Subsets of circulating T-lymphocytes mediating resistance to in vivo growth of a carcinogen-induced syngeneic rat tumor.
Crum ED
Cancer Res; 1984 Aug; 44(8):3196-201. PubMed ID: 6234986
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of methylcholanthrene-induced tumors tested by draining lymph node assay in syngeneic rats.
Ryzewska AG; Rybicka M; Kania A; Dabrowski M
Neoplasma; 1980; 27(5):533-42. PubMed ID: 7231610
[TBL] [Abstract][Full Text] [Related]
13. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
[TBL] [Abstract][Full Text] [Related]
14. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
16. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
Umanskiĭ IuA; Kushko LIa; Semenova-Kobzar' RA
Vopr Onkol; 1980; 26(2):42-6. PubMed ID: 7361493
[TBL] [Abstract][Full Text] [Related]
20. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
